Foreword. Abbreviations.
Section 1: Introduction.
1.1 How to use this book.
1.2 Basic Concepts in the Epidemiology and Control of Infectious
Disease.
1.3 Health Protection on-call.
Section 2: Common topics.
2.1 Meningitis and meningism.
2.2 Gastrointestinal infection.
2.3 Community acquired pneumonia.
2.4 Rash in pregnancy.
2.5 Rash and fever in children.
2.6 Illness in returning travellers.
2.7 Sexually Transmitted Infections.
2.8 Jaundice.
2.9 Infection in the immunocompromised.
2.10 Blood borne viral infections.
2.11 Vaccine Queries.
2.12 Individual measures against infections.
Section 3: Diseases.
3.1 Amoebic dysentery.
3.2 Anthrax.
3.3 Bacillus cereus.
3.4 Botulism.
3.5 Brucellosis.
3.6 Burkholderia.
3.7 Campylobacter.
3.8 Chickenpox and shingles (varicella-zoster infections).
3.9 Chikungunya.
3.10 Chlamydophila pneumoniae.
3.11 Chlamydophila psittaci.
3.12 Chlamydia trachomatis (genital).
3.13 Cholera.
3.14 CJD and other human transmissible spongiform
encephalopathies.
3.15 Clostridium difficile.
3.16 Clostridium perfringens.
3.17 Coxsackievirus infections.
3.18 Cryptosporidiosis.
3.19 Cyclosporiasis.
3.20 Cytomegalovirus.
3.21 Dengue fever.
3.22 Diphtheria.
3.23 Encephalitis, acute.
3.24 Enterococci, including glycopeptide-resistant enterococci
(GRE).
3.25 Epstein?Barr virus.
3.26 Escherichia coli O157 (and other E. coli gastroenteritis).
3.27 Giardiasis.
3.28 Gonorrhoea, syphilis and other acute STIs.
3.29 Hantavirus.
3.30 Head lice.
3.31 Helicobacter pylori.
3.32 Hepatitis A.
3.33 Hepatitis B.
3.34 Hepatitis C.
3.35 Delta hepatitis.
3.36 Hepatitis E.
3.37 Herpes simplex.
3.38 Haemophilus influenzae type b (Hib).
3.39 HIV.
3.40 Influenza.
3.41 Japanese B encephalitis.
3.42 Kawasaki Syndrome.
3.43 Legionellosis.
3.44 Leprosy.
3.45 Leptospirosis.
3.46 Listeria.
3.47 Lyme disease.
3.48 Malaria.
3.49 Measles.
3.50 Meningococcal infection.
3.51 Molluscum contagiosum.
3.52 MRSA (methicillin-resistant Staphylococcus aureus).
3.53 Mumps.
3.54 Mycoplasma.
3.55 Norovirus.
3.56 Paratyphoid fever.
3.57 Parvovirus B19 (fifth disease).
3.58 Plague.
3.59 Pneumococcal infection.
3.60 Poliomyelitis.
3.61 Q fever.
3.62 Rabies.
3.63 Relapsing Fever.
3.64 Respiratory syncytial virus (RSV).
3.65 Ringworm.
3.66 Rotavirus.
3.67 Rubella.
3.68 Salmonellosis.
3.69 Severe Acute Respiratory Syndrome (SARS).
3.70 Scabies
3.71 Shigella.
3.72 Smallpox.
3.73 Staphylococcal food poisoning.
3.74 Streptococcal infections.
3.75 Tetanus.
3.76 Threadworms.
3.77 Tick-borne encephalitis.
3.78 Toxocara.
3.79 Toxoplasmosis.
3.80 Tuberculosis.
3.81 Tularaemia.
3.82 Typhoid fever.
3.83 Rickettsial infections (incl. Typhus) Ehrlichia and
Bartonella.
3.84 Vibrio parahaemolyticus.
3.85 Viral haemorrhagic fevers.
3.86 Warts and verrucae.
3.87 West Nile Virus.
3.88 Whooping cough.
3.89 Yellow fever.
3.90 Yersiniosis.
3.91 Other organisms.
Section 4: Services and organisations.
4.1 Surveillance of communicable disease.
4.2 Managing infectious disease incidents and outbreaks.
4.3 Infection Prevention and Control in the Community.
4.4 Healthcare Associated Infection.
4.5 Antimicrobial Resistance.
4.6 Risks to and from Health Care Workers.
4.7 Co-ordination of immunisation services.
4.8 Services for sexual health and HIV infection.
4.9 Services for tuberculosis control.
4.10 Travel Health.
4.11 Pandemic Preparedness and the Influenza A H1N1 2009
Pandemic.
4.12 Non-infectious environmental hazards.
4.13 Managing acute chemical incidents.
4.14 Managing acute radiation incidents.
4.15 Deliberate release of biological, chemical or radiological
agents.
4.16 Media Relations and Crisis Communication.
4.17 Clinical Governance and Audit.
4.18 Global health.
Section 5: Communicable disease control in Europe.
5.1 WHO and International Health Regulations (IHR).
5.2 Collaboration within the European Union.
5.3 Detailed national example: organisational arrangements for
health protection: England, 2010.
5.4 Austria.
5.5 Belgium.
5.6 Bulgaria.
5.7 Cyprus.
5.8 Czech Republic.
5.9 Denmark.
5.10 Estonia.
5.11 Finland.
5.12 France.
5.13 Germany.
5.14 Greece.
5.15 Hungary.
5.16 Iceland.
5.17 Ireland.
5.18 Italy.
5.19 Latvia.
5.20 Lithuania.
5.21 Luxembourg.
5.22 Malta.
5.23 The Netherlands.
5.24 Norway.
5.25 Poland.
5.26 Portugal.
5.27 Romania.
5.28 Slovakia.
5.29 Slovenia.
5.30 Spain.
5.31 Sweden.
5.32 Switzerland.
5.33 United Kingdom.
Appendix 1 Useful addresses and telephone numbers.
Appendix 2 Guidance documents and books.
Index.
Jeremy Hawker is Regional Epidemiologist for the HealthProtection Agency, West Midlands; Registrar of the UK Faculty ofPublic Health, UK Norman Begg is Chief Medical Officer, GlaxoSmithKlineBiologicals, Wavre, Belgium Iain Blair is Associate Professor, Department ofCommunity Medicine, Faculty of Medicine and Health Sciences, UnitedArab Emirates University Ralf Reintjes is Professor of Epidemiology and PublicHealth Surveillance, Hamburg, Germany; Adjunct Professor ofInfectious Disease Epidemiology, Tampere, Finland Julius Weinberg is Vice Chancellor, Kingston University,London, UK Professor Karl Ekdahl is Head of Public Health Capacityand Communication Unit, European Centre for Disease Prevention andControl (ECDC), Stockholm, Sweden
 |
Ask a Question About this Product More... |
|
